Koeberl, Dwight D <br/><br/>
Adjunctive albuterol enhances the response to enzyme replacement therapy in late-onset Pompe disease.  [electronic resource] 

 -  FASEB journal : official publication of the Federation of American Societies for Experimental Biology  May 2014 
 - 2171-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1530-6860 
<br/><br/><label>Standard No.: </label>10.1096/fj.13-241893  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenergic beta-2 Receptor Agonists--therapeutic use<br/>Albuterol--therapeutic use<br/>Biopsy<br/>Electrocardiography<br/>Enzyme Replacement Therapy--methods<br/>Female<br/>Glycogen Storage Disease Type II--drug therapy<br/>Hand Strength<br/>Humans<br/>Male<br/>Muscle, Skeletal--metabolism<br/>Pilot Projects<br/>Quadriceps Muscle--metabolism<br/>Receptor, IGF Type 2--metabolism<br/>Time Factors<br/>Treatment Outcome<br/>Walking